POZEN Inc. (POZN), a pharmaceutical company, said the United States Patent and Trademark Office has issued to POZEN U.S. Patent 8,206,741 titled 'Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs'. This patent comprises claims to pharmaceutical compositions containing aspirin and a proton pump inhibitor or PPI.
POZEN's PA combination drug candidates are covered under this patent. The '741 patent is the second U.S. patent issued to POZEN for the coordinated delivery of NSAIDs, but the first in which the claims are focused on aspirin-based products.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.